Coagulex Overview

  • Founded
  • 2013
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business
  • Investors
  • 1

Coagulex General Information


Developer of coagulation assessment tools designed to focus on the development, manufacture and sale of hand-held MEMS-based point of injury coagulation assessment tools. The company's tools provide actionable results within 120 seconds without the need for pre-calibration and with limited blood sampling.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Primary Office
  • 1120 Nasa Parkway
  • Suite 600
  • Houston, TX 77058
  • United States
+1 (832) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Coagulex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 000 Completed Out of Business
3. Early Stage VC 13-Feb-2018 00000 000 Completed Startup
2. Later Stage VC $2M Completed Startup
1. Early Stage VC (Series A) 01-Aug-2014 $2M $2M 000 Completed Startup
To view Coagulex’s complete valuation and funding history, request access »

Coagulex Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 000
To view Coagulex’s complete cap table history, request access »

Coagulex Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CitareTx Investment Partners Venture Capital Minority 000 0000 000000 0
To view Coagulex’s complete investors history, request access »